PreveCeutical Medical (TSE:PREV) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
PreveCeutical Medical’s subsidiary, BioGene Therapeutics, has appointed Dr. Barry Ticho to its Scientific Advisory Board, leveraging his seasoned expertise in drug development and biotechnology. Dr. Ticho’s impressive career includes leadership roles at Stoke Therapeutics and contributions to companies like Verve and Moderna, marking significant advancements in treating various diseases. This strategic appointment is expected to enhance BioGene’s initiatives in developing innovative therapies.
For further insights into TSE:PREV stock, check out TipRanks’ Stock Analysis page.
